In Alzheimer disease, paired helical filaments accumulate in the neuron, and amyloid fibers are found in the extracellular space in the neuropil and brain vessels. Amyloid and paired helical filaments are morphologically distinct. Although messenger RNA that encodes the amyloid has also been shown in several tissues, including brain, the intracellular expression of the protein has not been observed. By using monoclonal antibodies to a synthetic amyloid (3 peptide (2-4), whereas mainly ubiquitin (5, 6) and microtubule-associated protein tau (7-15) have been shown in PHF. Tau, a family of closely related polypeptides with an average molecular mass of 58 kDa, is abnormally phosphorylated in PHF and probably also contains other alterations (16-18).
Alzheimer disease/senile dementia of the Alzheimer type (AD/SDAT) are characterized neuropathologically by the accumulation of two types of aberrant fibrils, the paired helical filaments (PHF) and the amyloid. PHF are intraneuronal and accumulate in bundles of parallel fibrils, called tangles, in the neuronal cell bodies, their dendrites, and the dystrophic neurites of the neuritic (senile) plaques. In contrast, amyloid is not found within the neurons and their processes but occurs extracellularly in association with the plaques either as wisps in the neuropil among the plaque neurites or as a concentrated mass in the center forming the plaque core (1) . Frequently accumulations of amyloid are also found in the neuropil around the vessels and within the vessel walls. Amyloid is morphologically readily distinguishable from the PHF by the smaller dimensions of its flibrils and their organization in irregular clusters. Plaque and cerebrovascular amyloid are primarily made up of a 40-to 42-amino acid residue peptide, called the P3 peptide or A4 peptide (2) (3) (4) , whereas mainly ubiquitin (5, 6 ) and microtubule-associated protein tau (7) (8) (9) (10) (11) (12) (13) (14) (15) have been shown in PHF. Tau, a family of closely related polypeptides with an average molecular mass of 58 kDa, is abnormally phosphorylated in PHF and probably also contains other alterations (16) (17) (18) .
Sequences of amyloid P peptide have also been reported in preparations enriched in PHF (19) (20) (21) . However, it has not been resolved as yet whether the amyloid peptide is actually a component of the PHF or a contaminant.
MATERIALS AND METHODS
Antibodies and Immunological Reagents. Monoclonal antibodies (mAbs) to a synthetic peptide corresponding to the first 24 amino acids of the ,B peptide were generated as previously described (22) . All antibodies reacted with the 17-24 amino acid sequence fragment of 83 peptide in ELISA and with plaque and vascular amyloid by immunocytochemistry (22) . For the studies in the present paper, culture supernatants of mAb to amyloid at dilutions of 1:2-1:20 were used (IgG subclass in parentheses): 4G5 (IgGi), 2B8 (IgGl), 2F9 (IgGl), 4E11 (IgG2a), 4G8 (IgG2b). mAb tau-1 to tau (IgG2a, ascites, 1:50,000) was the generous gift of L. I. Binder (University of Alabama, Birmingham). Mouse ascites fluid from plasmacytoma line MOPC21 was purchased from Litton Bionetics. Reagents for the avidin-biotin complex technique were purchased from Vector Laboratories, and reagents for the peroxidase-anti-peroxidase technique were from SternbergerMeyer Immunocytochemicals (Jarrettsville, MD). Alkaline phosphatase-conjugated antibody to mouse IgG and the alkaline phosphatase color development reagents 5-bromo4-chloro-3-indolyl phosphate (p-toluidine salt) and nitroblue tetrazolium chloride were from Bio-Rad.
Immunoblots. Electrophoresis on NaDodSO4/polyacrylamide gels (80 x 60 x 75 mm slab) was performed according to Laemmli (23) . Proteins were transferred to Immobilon (Millipore) in 25 mM Tris/0.7 M glycine/20% (vol/vol) methanol (24, 25) (27) . The tissue was embedded in Paraplast, and 6-,um serial sections were prepared. Neuronal cell bodies were isolated from AD/SDAT frontal cortex as described previously (28) , and cell smears were dried onto gelatin-coated slides and either fixed with 10% (vol/vol) neutral formalin or with 10o neutral formalin containing 5% (vol/vol) dimethyl sulfoxide for 10 min at room temperature (29) or fixed with -20°C acetone for 3 min. Some sections Abbreviations: AD/SDAT, Alzheimer disease/senile dementia of the Alzheimer type; PHF, paired helical filaments; mAb, monoclonal antibody. *To whom reprint requests should be addressed.
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were treated with 86% (vol/vol) formic aci prior to immunostaining according to the met! et al. (30) . Immunocytochemistry was perft sections or cell smears by using the avidintechnique (29 mAb to amyloid was used as a control antibody. In sections of Alzheimer brain, the mAb reacted strongly with plaque and vascular amyloid (Fig. 2) . The latter was found as heavy deposits within the walls of the cortical and reacted with the meningeal vessels and in addition as loose fibrous accumu-;sreactivity was lations either perivascular or scattered in the neuropil of the ptides in micromost affected areas. Similarly, in the brains of non-demented owever, in total aged individuals, the sparsely occurring plaque and vascular ,ere labeled. In amyloid was also stained strongly. On treatment of the ed control indisections with formic acid prior to application of the antibodptide doublet of ies, a dramatic increase in the number and intensity of lypeptide bands immunostained plaque, vascular, and amorphous amyloid deposits in the neuropil was observed (data not shown).
In addition to the extraneuronal amyloid, dark labeling of accumulations of intracellular granules in various types of 8 9 neurons in cerebral and cerebellar cortices and spinal cord was observed (Figs. 3 and 4) . Dilutions of the culture supernatants for optimal staining ranged from 1:10 to 1:50 depending upon the myeloma line and was the same in each case for both intracellular and extracellular amyloid staining. The immunostaining was not affected when the salt concentration was increased from 0.15 M to 0.3 M and 0.05% Tween-20 was added to the antibodies. Like the extraneu-_ ronal amyloid, the immunoreactivity of this intraneuronal -X ir~.material increased in the formic acid-treated tissue sections (data not shown). The intraneuronal amyloid immunoreactivity appeared to be expressed in cerebellum and cerebrum _ s of AD/SDAT as well as of the non-Alzheimer control group irrespective of age or postmortem time investigated. In the cerebellum, the labeling was most conspicuous in the cytoplasm ofthe Purkinje cells, which were almost all stained in the cases studied ranging from a 38-year-old control individual to an 81-year-old Alzheimer patient (Fig. 3 a-d) . Sometimes the immunopositive grains were seen along almost the whole length of the apical dendrite extending into the molecular layer (Fig. 3b) . On parallel sections that had been stained for polysaccharides with periodic acid/Schiff reagent, accumulations of periodic acid/Schiff reagentpositive material were also seen in the perikarya of the Purkinje cells (Fig. 3e) . Amyloid immunostaining was also ptide and to tau on found in the cells of the granular layer (Fig. 3c) In hippocampus, the amyloid immunoreactivity was presserved. The mAb ent in the cytoplasm of both granular and pyramidal neurons ppg), tau (lane 4, (Fig. 4 a, (Fig. 4 a and b) . However, immunostaining of nyloid antibodies. the adjacent sections with antibodies to tau or PHF (18) olyacrylamide gel revealed that the tangles were less frequently present in these ins were electroneurons than the amyloid-positive material and were always Is (5-22% acrylfibrillar and not globular (Fig. 4c) . In tissue sections coune positions of the terstained with thioflavine S. the coexistence of thioflavine-)p to bottom: ov- the mAb to amyloid with the granular structures barely or not at all visible (Fig. 3]) . In preparations ofisolated neuronal cell bodies from AD/SDAT brain, only occasionally weakly stained intracellular amyloid-positive material was observed Ae# t¢ i *s 471i; regardless of the fixative used. In contrast, in both Perfixtreated tissue and isolated neurons, Alzheimer tangles were easily recognizable by their characteristic shape and fibrillar appearance when stained with antibodies to PHF or to tau (data not shown).
DISCUSSION
The typical amyloid fibrils are located extraneuronally in the neuropil and vessels of the brain. Although, by in situ hybridization and Northern blots, messenger RNA that encodes amyloid precursor protein has been shown recently in several tissues including the neurons of the neocortex (34, 35) , the intraneuronal presence of the protein itself has not been demonstrated previously. The present study shows that P3-peptide-reactive protein is indeed expressed in neurons of cerebrum, cerebellum, and spinal cord. This protein is seen in brains ofall ages studied so far, ranging from 38 to 83 years, with or without Alzheimer neuropathology, and thus seems to be a normally occurring neuronal protein which might not be age dependent.
According to sequence analysis of human brain cDNA, the 3 peptide has been hypothesized to be part of a 695-amino acid residue precursor protein with the characteristics of a cell surface receptor (4); in vitro translation resulted in a 92.5-kDa polypeptide (36) . The precursor protein may also have an insert corresponding to a protease inhibitor domain (37, 38) . The doublet labeled by the amyloid antibodies on immunoblots of Alzheimer brain homogenate may thus represent these two species of precursor polypeptides. That their molecular masses are higher than those predicted from the cDNA sequences (about 85 kDa and 90 kDa) may be due to posttranslational modifications. For instance, the predicted precursor proteins contain two potential N-glycosylation sites (4) . Closer to the molecular mass of the hypothetical amyloid precursor protein is the molecular mass of the amyloid-positive polypeptide in calf brain homogenate (estimated at 93 kDa). It is not resolved as yet whether this is due to age or species differences. The amyloid-reactive polypeptide bands with molecular masses below 93 kDa might represent the precursor protein in different metabolic stages. Similarly, the intraneuronal amyloid-reactive material observed by us in tissue sections is most likely the precursor protein at a certain level of processing by the cell.
In distilled water or in saline, the synthetic ( peptide spontaneously polymerizes into fibrils that are morphologi-cally very similar to the amyloid fibrils seen in situ (39, 40 
